Showing results (341-350 of 393) with videos related to

Sort By:
Pageof 40
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2006
Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumorsMatthew H Kulke, Emily K Bergsland, David P Ryan, et al.
Plos One|June 16, 2012
Phase I study of cetuximab, irinotecan, and vandetanib (ZD6474) as therapy for patients with previously treated metastastic colorectal cancerJeffrey A Meyerhardt, Marek Ancukiewicz, Thomas A Abrams, et al.
Neurology|September 12, 2001
Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosisF Fazekas, S Strasser-Fuchs, H Kollegger, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 25, 2012
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndromeM Khalil, C Enzinger, C Langkammer, et al.
Neurology|June 10, 2010
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypesN De Stefano, A Giorgio, M Battaglini, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 4, 2015
Regional cortical thinning in multiple sclerosis and its relation with cognitive impairment: A multicenter studyJ M Tillema, H E Hulst, M A Rocca, et al.
Advances in Radiation Oncology|May 11, 2026
Acute Toxicity From Short-Course Radiation Therapy for Rectal Cancer: A Single-Institution ExperienceShane S Neibart, Katie N Lee, Yu-Hui Chen, et al.
European Radiology|May 6, 2009
A search for new MRI criteria for dissemination in space in subjects with a clinically isolated syndromeT Korteweg, M Tintore, B M J Uitdehaag, et al.
The Oncologist|May 14, 2014
Phase II and pharmacodynamic study of autophagy inhibition using hydroxychloroquine in patients with metastatic pancreatic adenocarcinomaBrian M Wolpin, Douglas A Rubinson, Xiaoxu Wang, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 11, 2011
A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinomaJ A Chan, L S Blaszkowsky, P C Enzinger, et al.
Pageof 40